• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用一种专用于血清和血浆基质的化学发光免疫分析法测定人脑脊液中的甲氨蝶呤。

Measurement of methotrexate in human cerebrospinal fluid using a chemiluminescence immunoassay intended for serum and plasma matrices.

机构信息

Department of Pharmacy, University of Miyazaki Hospital, Miyazaki, Japan.

Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

出版信息

J Clin Lab Anal. 2021 Mar;35(3):e23661. doi: 10.1002/jcla.23661. Epub 2020 Nov 22.

DOI:10.1002/jcla.23661
PMID:33225528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7957986/
Abstract

BACKGROUND

The concentration of MTX in blood is often measured quickly and easily by immunoassays. Thus, immunoassays may facilitate the easy determination of the concentration of MTX in the cerebrospinal fluid (CSF). In this study, we measured methotrexate (MTX) concentrations in the CSF using a high-performance liquid chromatography (HPLC) method intended for analyzing CSF matrices and a chemiluminescence immunoassay (CLIA) method intended for assessing serum and plasma matrices and verified the differences in the results of the two methods.

METHODS

HPLC analysis for MTX in the CSF was performed using a Prominence UFLC system with a C18 column. The HPLC method was validated in accordance with the 2018 FDA guideline. The CLIA method was performed using an ARCHITECT i1000SR system intended for serum and plasma matrices. A total of 47 CSF samples (14 clinical and 33 spiked specimens) were analyzed using the two methods.

RESULTS

The HPLC method passed the validation criteria. The concentration of MTX in the same sample, determined using the HPLC and CLIA methods, differed proportionally; the percent difference in the concentrations averaged -23.0% (95% confidence interval: -36.9% to -9.1%) as revealed by the Bland-Altman plot. The relationship between the measured values, evaluated using the Passing-Bablok regression, was as follows: HPLC = 1.205 × CLIA - 0.024.

CONCLUSION

The equation deduced in this study can be used to correct the concentration of MTX measured using the CLIA method.

摘要

背景

通常可以通过免疫测定法快速、轻松地测量血液中的 MTX 浓度。因此,免疫测定法可能有助于轻松确定脑脊液(CSF)中 MTX 的浓度。在这项研究中,我们使用旨在分析 CSF 基质的高效液相色谱(HPLC)方法和旨在评估血清和血浆基质的化学发光免疫测定(CLIA)方法来测量 CSF 中的甲氨蝶呤(MTX)浓度,并验证了两种方法的结果之间的差异。

方法

使用 Prominence UFLC 系统和 C18 柱对 CSF 中的 MTX 进行 HPLC 分析。HPLC 方法按照 2018 年 FDA 指南进行验证。CLIA 方法使用 ARCHITECT i1000SR 系统进行,该系统用于血清和血浆基质。使用两种方法分析了 47 个 CSF 样本(14 个临床样本和 33 个加标样本)。

结果

HPLC 方法通过了验证标准。使用 HPLC 和 CLIA 方法测定同一样本中的 MTX 浓度呈比例差异;Bland-Altman 图显示,浓度的平均差异为 -23.0%(95%置信区间:-36.9%至-9.1%)。通过 Passing-Bablok 回归评估的测定值之间的关系如下:HPLC = 1.205 × CLIA - 0.024。

结论

本研究推导出的方程可用于校正 CLIA 方法测量的 MTX 浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/7c6a8531cdc8/JCLA-35-e23661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/9669246a0c98/JCLA-35-e23661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/eb0978bf60e5/JCLA-35-e23661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/f7a5cf2eb1af/JCLA-35-e23661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/7c6a8531cdc8/JCLA-35-e23661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/9669246a0c98/JCLA-35-e23661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/eb0978bf60e5/JCLA-35-e23661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/f7a5cf2eb1af/JCLA-35-e23661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78cb/7957986/7c6a8531cdc8/JCLA-35-e23661-g005.jpg

相似文献

1
Measurement of methotrexate in human cerebrospinal fluid using a chemiluminescence immunoassay intended for serum and plasma matrices.采用一种专用于血清和血浆基质的化学发光免疫分析法测定人脑脊液中的甲氨蝶呤。
J Clin Lab Anal. 2021 Mar;35(3):e23661. doi: 10.1002/jcla.23661. Epub 2020 Nov 22.
2
Analysis of serum homocysteine in the laboratory practice - comparison of the direct chemiluminescence immunoassay and high performance liquid chromatography coupled with fluorescent detection.血清同型半胱氨酸分析在实验室实践中的应用——直接化学发光免疫分析法与高效液相色谱-荧光检测法的比较。
Biochem Med (Zagreb). 2020 Oct 15;30(3):030703. doi: 10.11613/BM.2020.030703. Epub 2020 Aug 5.
3
A UPLC-MS/MS method for analysis of vancomycin in human cerebrospinal fluid and comparison with the chemiluminescence immunoassay.一种用于分析人脑脊液中万古霉素的超高效液相色谱-串联质谱法及其与化学发光免疫分析法的比较。
Biomed Chromatogr. 2017 Aug;31(8). doi: 10.1002/bmc.3939. Epub 2017 Feb 20.
4
Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.新型甲氨蝶呤结构化学发光免疫分析法的评估:对药代动力学监测的临床影响
Ther Drug Monit. 2017 Oct;39(5):492-498. doi: 10.1097/FTD.0000000000000434.
5
A simple, rapid and reliable liquid chromatography-mass spectrometry method for determination of methotrexate in human plasma and its application to therapeutic drug monitoring.一种用于测定人血浆中甲氨蝶呤的简单、快速且可靠的液相色谱-质谱法及其在治疗药物监测中的应用。
Biomed Chromatogr. 2015 Aug;29(8):1197-202. doi: 10.1002/bmc.3408. Epub 2015 Jan 13.
6
Simultaneous Determination of Methotrexate Concentrations in Human Plasma and Cerebrospinal Fluid Using Two-Dimensional Liquid Chromatography: Applications in Primary Central Nervous System Lymphoma.使用二维液相色谱法同时测定人血浆和脑脊液中甲氨蝶呤浓度:在原发性中枢神经系统淋巴瘤中的应用
World J Oncol. 2024 Oct;15(5):825-836. doi: 10.14740/wjon1910. Epub 2024 Sep 16.
7
Determination of serum methotrexate and 7-hydroxymethotrexate concentrations. Method evaluation showing advantages of high-performance liquid chromatography.血清甲氨蝶呤和7-羟基甲氨蝶呤浓度的测定。方法评估显示高效液相色谱法的优势。
J Chromatogr. 1985 Jan 11;337(1):81-90.
8
Determination of methotrexate in serum: the aca MTHO immunoassay and HPLC compared.血清中氨甲蝶呤的测定:aca MTHO免疫测定法与高效液相色谱法的比较
J Clin Chem Clin Biochem. 1990 Dec;28(12):951-3.
9
Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.四种免疫分析法与 HPLC 法测定甲氨蝶呤治疗药物监测的比较:羟化代谢产物水平的影响及对临床阈值的影响。
J Oncol Pharm Pract. 2022 Jan;28(1):55-63. doi: 10.1177/1078155220983407. Epub 2021 Jan 11.
10
Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay.采用超高效液相色谱-串联质谱法同时测定人全血中环孢素和他克莫司,并与化学发光微粒子免疫法进行比较。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jun 15;1087-1088:36-42. doi: 10.1016/j.jchromb.2018.04.028. Epub 2018 Apr 13.

引用本文的文献

1
A pH-Responsive DNA Tetrahedron/Methotrexate Drug Delivery System Used for Rheumatoid Arthritis Treatment.一种用于类风湿性关节炎治疗的pH响应性DNA四面体/甲氨蝶呤药物递送系统。
J Funct Biomater. 2023 Nov 3;14(11):541. doi: 10.3390/jfb14110541.
2
Efficiency of antioxidant Avenanthramide-C on high-dose methotrexate-induced ototoxicity in mice.抗氧化剂 Avenanthramide-C 对大剂量甲氨蝶呤诱导的小鼠耳毒性的作用。
PLoS One. 2022 Mar 30;17(3):e0266108. doi: 10.1371/journal.pone.0266108. eCollection 2022.
3
Development and Validation of an HPLC Method for Analysis of Topotecan in Human Cerebrospinal Fluid and Its Application in Elimination Evaluation of Topotecan after Intraventricular Injection.

本文引用的文献

1
Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.检测降钙素原的新型化学发光免疫分析方法的建立。
J Immunol Methods. 2020 Sep-Oct;484-485:112829. doi: 10.1016/j.jim.2020.112829. Epub 2020 Jul 14.
2
Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose Methotrexate.采用液相色谱-串联质谱法测定血浆和脑脊液中的甲氨蝶呤、7-羟基甲氨蝶呤及2,4-二氨基-N-甲基蝶酸,并应用于大剂量甲氨蝶呤的药代动力学分析
J Liq Chromatogr Relat Technol. 2016;39(16):745-751. doi: 10.1080/10826076.2016.1243558. Epub 2016 Oct 10.
3
人脑脊液中拓扑替康分析的高效液相色谱法的建立与验证及其在脑室内注射后拓扑替康消除评价中的应用
Cancers (Basel). 2021 Sep 16;13(18):4643. doi: 10.3390/cancers13184643.
Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
新型甲氨蝶呤结构化学发光免疫分析法的评估:对药代动力学监测的临床影响
Ther Drug Monit. 2017 Oct;39(5):492-498. doi: 10.1097/FTD.0000000000000434.
4
A UPLC-MS/MS method for analysis of vancomycin in human cerebrospinal fluid and comparison with the chemiluminescence immunoassay.一种用于分析人脑脊液中万古霉素的超高效液相色谱-串联质谱法及其与化学发光免疫分析法的比较。
Biomed Chromatogr. 2017 Aug;31(8). doi: 10.1002/bmc.3939. Epub 2017 Feb 20.
5
Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay:  Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.甲氨蝶呤化学发光微粒免疫分析的评估:与荧光偏振免疫分析和液相色谱-串联质谱法的比较
Am J Clin Pathol. 2016 Jul;146(1):119-24. doi: 10.1093/ajcp/aqw088. Epub 2016 Jun 29.
6
Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.两种商用甲氨蝶呤免疫分析方法分析性能的直接比较以及与液相色谱-质谱联用和原荧光偏振免疫分析的对比
Clin Chem Lab Med. 2016 May;54(5):823-31. doi: 10.1515/cclm-2015-0578.
7
Simple and reliable HPLC method for the monitoring of methotrexate in osteosarcoma patients.用于监测骨肉瘤患者甲氨蝶呤的简单可靠的高效液相色谱法。
J Chromatogr Sci. 2014 Aug;52(7):590-5. doi: 10.1093/chromsci/bmt081. Epub 2013 Jun 25.
8
Analysis of methotrexate and its eight metabolites in cerebrospinal fluid by solid-phase extraction and triple-stacking capillary electrophoresis.固相萃取-三重堆积毛细管电泳法分析脑脊液中甲氨蝶呤及其 8 种代谢物。
Anal Bioanal Chem. 2010 Nov;398(5):2183-90. doi: 10.1007/s00216-010-4152-3. Epub 2010 Sep 6.
9
Development of enzyme-linked immunosorbent assay (ELISA) for the detection of neomycin residues in pig muscle, chicken muscle, egg, fish, milk and kidney.用于检测猪肌肉、鸡肌肉、鸡蛋、鱼肉、牛奶和肾脏中新霉素残留的酶联免疫吸附测定法(ELISA)的开发。
Meat Sci. 2009 May;82(1):53-8. doi: 10.1016/j.meatsci.2008.12.003. Epub 2008 Dec 14.
10
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.成人骨肉瘤患者大剂量甲氨蝶呤治疗:群体药代动力学研究及新的有限采样策略验证
Anticancer Drugs. 2008 Mar;19(3):267-73. doi: 10.1097/cad.0b013e3282f21376.